COMMUNIQUÉS West-GlobeNewswire

Tom Ripp Joins Analogic as President, Security and Detection
05/07/2018
PEABODY, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation, a leading provider of advanced imaging technologies to the medical imaging and security industries, today announced and welcomed the addition of Mr [...]
Molina Healthcare Announces Second Quarter 2018 Earnings Release and Conference Call Dates
05/07/2018
LONG BEACH, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the second quarter ended June 30, 2018. Molina Healthcare will issue [...]
NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology
05/07/2018
WALTHAM, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that [...]
OSE Immunotherapeutics Receives a €435,000 Translational Research Grant to Develop Precision Medicine Targeting for Tedopi®
05/07/2018
Funding through the Eurostars European Programme, led in France by Bpifrance NANTES, France, July 05, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE) today announces that the Company [...]
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC
05/07/2018
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC Lille (France), Cambridge (Massachusetts, United States), July 5, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), is a biopharmaceutical company focused on [...]
GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC
05/07/2018
GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC Lille (France), Cambridge (Massachusetts, Etats-Unis), le 5 juillet 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique [...]
Lexaria DehydraTECH Shows Promise in Nervous System Disorders -- CFN Media
05/07/2018
SEATTLE, WA, July 05, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
05/07/2018
FIT Biotech Oy Company release July 5, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Hemostemix Formalizes World-Class Scientific Advisory Board
05/07/2018
CALGARY, Alberta, July 05, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX-V:HEM) is pleased to announce the formalization of its Scientific Advisory Board (“SAB”). Members of the SAB [...]
Top Solar System Engineer Joins International Endeavors Corp.
05/07/2018
TEMECULA, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC: IDVV) announces today it has secured renewable energy expert Jason Andrade as a consultant for the company [...]
IntelGenx Receives CIPO Notice of Allowance for Loxapine VersaFilm™ Patent
05/07/2018
SAINT LAURENT, Quebec, July 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) (“IntelGenx” or the “Company”), a leading oral drug delivery company primarily focused on the development and [...]
Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine
05/07/2018
- Results support the use of TPOXX to treat smallpox, a highly contagious and lethal virus that poses significant bioterror threat - NEW YORK, July 05, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: [...]
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study
05/07/2018
DEVON, Pa., July 05, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Theratechnologies Announces Financial Results for the Second Quarter of 2018
05/07/2018
MONTRÉAL, July 05, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced its financial results for the second quarter ended May 31, 2018. Second quarter 2018 financial highlights [...]
Theratechnologies annonce ses résultats financiers du deuxième trimestre de 2018
05/07/2018
MONTRÉAL, 05 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui ses résultats financiers pour le deuxième trimestre clos le 31 mai 2018. Faits saillants [...]
Emblem Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commission (AGLC)
05/07/2018
PARIS, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") is pleased to announce that its wholly owned subsidiary, Emblem Cannabis Corporation, one of Canada’s [...]
Ogilvy CommonHealth Worldwide continues to fuel the network’s creative department with promotions and new talent
05/07/2018
PARSIPPANY, N.J., July 05, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced three promotions and one new hire [...]
Clementia Appoints Industry Executive Shawn Tomasello to its Board of Directors
05/07/2018
Accomplished Biopharma Leader Brings Over 30 Years of Experience Leading Strategic and Commercial Efforts MONTREAL, July 05, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage [...]
Clementia nomme Shawn Tomasello, une cadre chevronnée de l’industrie, au sein de son conseil d’administration
05/07/2018
Une leader accomplie de la biopharmaceutique qui apporte 30 ans d’expérience en direction d’initiatives stratégiques et commerciales MONTRÉAL, 05 juill. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: [...]

Pages